Targeting the HIF pathway in inflammation and immunity

Current Opinion in Pharmacology

Volumn 13, Issue 4, 2013, Pages 646-653

  Scholz, Carsten C ^a   Taylor, Cormac T ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; ACRIFLAVINE; AMINOFLAVONE; BORTEZOMIB; COBALT; DEFEROXAMINE; DIMETHYLOXALLYLGLYCINE; ECHINOMYCIN; ENZYME INHIBITOR; FG 4497; FLAVONE DERIVATIVE; HYDRALAZINE; HYDROXYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR; JNJ 1935; RAPAMYCIN; UNCLASSIFIED DRUG;

ADAPTATION; ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL FUNCTION; CELL SURVIVAL; CELLULAR IMMUNITY; COLITIS; DENDRITIC CELL; DOWN REGULATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG TARGETING; EPITHELIUM CELL; HUMAN; HYPOXIA; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SEPTIC SHOCK; UPREGULATION;

EID: 84885950065     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2013.04.009     Document Type: Review

References (60)

1. Taylor CT, Moncada S: Nitric oxide, cytochrome c oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol 2010, 30:643-647.
2. Chua YL, Dufour E, Dassa EP, Rustin P, Jacobs HT, Taylor CT, Hagen T: Stabilization of hypoxia-inducible factor-1alpha protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J Biol Chem 2010, 285:31277-31284.
3. Hagen T, Taylor CT, Lam F, Moncada S: Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on hif1alpha. Science 2003, 302:1975-1978. (Pubitemid 37523507)
4. Semenza GL: Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
5. Taylor CT, McElwain JC: Ancient atmospheres and the evolution of oxygen sensing via the hypoxia-inducible factor in metazoans. Physiology (Bethesda) 2010, 25:272-279.
6. Colgan SP, Taylor CT: Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 2010, 7:281-287.
7. Semenza GL: Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012, 33:207-214.
8. Kempf VA, Lebiedziejewski M, Alitalo K, Walzlein JH, Ehehalt U, Fiebig J, Huber S, Schutt B, Sander CA, Muller S, Grassl G et al.: Activation of hypoxia-inducible factor-1 in bacillary angiomatosis: evidence for a role of hypoxia-inducible factor- 1 in bacterial infections. Circulation 2005, 111:1054-1062. (Pubitemid 40354525)
9. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, Veale DJ, Fearon U: Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010, 62:711-721.
10. Taylor CT, Colgan SP: Hypoxia and gastrointestinal disease. J Mol Med 2007, 85:1295-1300. (Pubitemid 50004090)
11. Werth N, Beerlage C, Rosenberger C, Yazdi AS, Edelmann M, Amr A, Bernhardt W, von Eiff C, Becker K, Schafer A, Peschel A et al.: Activation of hypoxia inducible factor 1 is a general phenomenon in infections with human pathogens. PLoS ONE 2010, 5:e11576.
12. Kaelin WG Jr, Ratcliffe PJ: Oxygen sensing by metazoans: the central role of the hif hydroxylase pathway. Mol Cell 2008, 30:393-402. (Pubitemid 351681994)
13. Kaelin WG Jr: The von hippel-lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 2008, 8:865-873.
14. Maxwell PH: The hif pathway in cancer. Semin Cell Dev Biol 2005, 16:523-530. (Pubitemid 41247875)
15. Zhang N, Fu Z, Linke S, Chicher J, Gorman JJ, Visk D, Haddad GG, Poellinger L, Peet DJ, Powell F, Johnson RS: The asparaginyl hydroxylase factor inhibiting hif-1alpha is an essential regulator of metabolism. Cell Metab 2010, 11:364-378.
16. McNeill LA, Hewitson KS, Claridge TD, Seibel JF, Horsfall LE, Schofield CJ: Hypoxia-inducible factor asparaginyl hydroxylase (fih-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem J 2002, 367(Pt 3):571-575. (Pubitemid 35305697)
17. Cummins EP, Taylor CT: Hypoxia-responsive transcription factors. Pflugers Arch 2005, 450:363-371. (Pubitemid 41380694)
18. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH: Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 2004, 114:1098-1106. (Pubitemid 39578699)
19. Vannay A, Sziksz E, Prokai A, Veres G, Molnar K, Szakal DN, Onody A, Korponay-Szabo IR, Szabo A, Tulassay T, Arato A et al.: Increased expression of hypoxia-inducible factor 1alpha in coeliac disease. Pediatr Res 2010, 68:118-122.
20. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS et al.: Hif-1alpha is essential for myeloid cell-mediated inflammation. Cell 2003, 112:645-657. (Pubitemid 36331777)
21. Frede S, Freitag P, Otto T, Heilmaier C, Fandrey J: The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation. Cancer Res 2005, 65:4690-4697. (Pubitemid 40740805)
22. Frede S, Stockmann C, Freitag P, Fandrey J: Bacterial lipopolysaccharide induces hif-1 activation in human monocytes via p44/42 mapk and nf-kappab. Biochem J 2006, 396:517-527. (Pubitemid 44228166)
23. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M: Nf-kappab links innate immunity to the hypoxic response through transcriptional regulation of hif-1alpha. Nature 2008, 453: 807-811. (Pubitemid 351793778)
24. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W et al.: Control of t(h)17/ t(reg) balance by hypoxia-inducible factor 1. Cell 2011, 146:772-784.
25. Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, Volke M, Glasner J, Warnecke C, Wiesener MS, Eckardt KU et al.: Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 2008, 180:4697-4705.
26. Naldini A, Morena E, Pucci A, Miglietta D, Riboldi E, Sozzani S, Carraro F: Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1alpha and lipopolysaccharide. J Cell Physiol 2012, 227:587-595.
27. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A, Condliffe AM, Cowburn AS, Johnson N, Chilvers ER: Hypoxia-induced neutrophil survival is mediated by hif-1alpha-dependent nf-kappab activity. J Exp Med 2005, 201:105-115. (Pubitemid 40130088)
28. Wobben R, Husecken Y, Lodewick C, Gibbert K, Fandrey J, Winning S: Role of hypoxia inducible factor-1alpha for interferon synthesis in mouse dendritic cells. Biol Chem 2013, 394:495-505.
29. Clambey ET, McNamee EN, Westrich JA, Glover LE, Campbell EL, Jedlicka P, de Zoeten EF, Cambier JC, Stenmark KR, Colgan SP, Eltzschig HK: Hypoxia-inducible factor-1 alpha-dependent induction of foxp3 drives regulatory t-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA 2012, 109:E2784-E2793.
30. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H: Hif1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of th17 and treg cells. J Exp Med 2011, 208:1367-1376.
31. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, Berenfeld L, Wenger RH, Sitkovsky M: Cutting edge: hypoxiainducible factor 1alpha and its activation-inducible short isoform i.1 negatively regulate functions of cd4+ and cd8+ t lymphocytes. J Immunol 2006, 177:4962-4965. (Pubitemid 44527564)
32. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P, Ohta A, Lentsch AB, Lukashev D, Sitkovsky MV: Targeted deletion of hif- 1alpha gene in t cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2007, 2:e853.
33. Kojima H, Gu H, Nomura S, Caldwell CC, Kobata T, Carmeliet P, Semenza GL, Sitkovsky MV: Abnormal b lymphocyte development and autoimmunity in hypoxia-inducible factor 1alpha-deficient chimeric mice. Proc Natl Acad Sci USA 2002, 99:2170-2174. (Pubitemid 34169033)
34. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V: Cutting edge: essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharideinduced sepsis. J Immunol 2007, 178:7516-7519. (Pubitemid 46898018)
35. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, Zheng L et al.: Succinate is a danger signal that induces il-1b via hif-1a. Nature 2013, 496:238-242.
36. Comerford KM, Cummins EP, Taylor CT: C-jun nh2-terminal kinase activation contributes to hypoxia-inducible factor 1alpha-dependent p-glycoprotein expression in hypoxia. Cancer Res 2004, 64:9057-9061. (Pubitemid 39665517)
37. Comerford KM, Wallace TJ, Karhausen J, Louis NA, Montalto MC, Colgan SP: Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (mdr1) gene. Cancer Res 2002, 62:3387-3394. (Pubitemid 34651384)
38. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, Podolsky DK, Colgan SP: Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001, 193: 1027-1034. (Pubitemid 32436196)
39. Kong T, Westerman KA, Faigle M, Eltzschig HK, Colgan SP: Hifdependent induction of adenosine a2b receptor in hypoxia. FASEB J 2006, 20:2242-2250. (Pubitemid 44953854)
40. Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP: Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem 2006, 99:1616-1627. (Pubitemid 44845721)
41. Louis NA, Hamilton KE, Kong T, Colgan SP: Hif-dependent induction of apical cd55 coordinates epithelial clearance of neutrophils. FASEB J 2005, 19:950-959. (Pubitemid 40827716)
42. Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, Hansen KR, Thompson LF, Colgan SP: Ecto-50- nucleotidase (cd73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993-1002.
43. Fraisl P, Aragones J, Carmeliet P: Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 2009, 8:139-152.
44. Barrett TD, Palomino HL, Brondstetter TI, Kanelakis KC, Wu X, Haug PV, Yan W, Young A, Hua H, Hart JC, Tran DT et al.: Pharmacological characterization of 1-(5-chloro-6- (trifluoromethoxy)-1h-benzoimidazol-2-yl)-1h-pyrazole-4- carb oxylic acid (jnj-42041935), a potent and selective hypoxiainducible factor prolyl hydroxylase inhibitor. Mol Pharmacol 2011, 79:910-920.
45. Robinson A, Keely S, Karhausen J, Gerich ME, Furuta GT, Colgan SP: Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 2008, 134: 145-155. (Pubitemid 350309309)
46. Knowles HJ, Tian YM, Mole DR, Harris AL: Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor- 1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases. Circ Res 2004, 95:162-169. (Pubitemid 38988682)
47. Cummins EP, Seeballuck F, Keely SJ, Mangan NE, Callanan JJ, Fallon PG, Taylor CT: The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 2008, 134:156-165.
48. Tambuwala MM, Cummins EP, Lenihan CR, Kiss J, Stauch M, Scholz CC, Fraisl P, Lasitschka F, Mollenhauer M, Saunders SP, Maxwell PH et al.: Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 2010, 139:2093-2101.
49. Hams E, Saunders SP, Cummins EP, O'Connor A, Tambuwala MT, Gallagher WM, Byrne A, Campos-Torres A, Moynagh PM, Jobin C, Taylor CT et al.: The hydroxylase inhibitor dimethyloxallyl glycine attenuates endotoxic shock via alternative activation of macrophages and il-10 production by b1 cells. Shock 2011, 36:295-302.
50. Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS, Na KY: Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant 2010, 25:77-85.
51. Jamadarkhana P, Chaudhary A, Chhipa L, Dubey A, Mohanan A, Gupta R, Deshpande S: Treatment with a novel hypoxiainducible factor hydroxylase inhibitor (trc160334) ameliorates ischemic acute kidney injury. Am J Nephrol 2012, 36:208-218.
52. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schodel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C et al.: Donor treatment with a phd-inhibitor activating hifs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 2009, 106:21276-21281.
53. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH: Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008, 19:39-46.
54. Schofield CJ, Ratcliffe PJ: Oxygen sensing by hif hydroxylases. Nat Rev Mol Cell Biol 2004, 5:343-354. (Pubitemid 38579472)
55. Eltzschig HK, Carmeliet P: Hypoxia and inflammation. N Engl J Med 2011, 364:656-665.
56. Haeberle HA, Durrstein C, Rosenberger P, Hosakote YM, Kuhlicke J, Kempf VA, Garofalo RP, Eltzschig HK: Oxygenindependent stabilization of hypoxia inducible factor (hif)-1 during rsv infection. PLoS ONE 2008, 3:e3352.
57. Hartmann H, Eltzschig HK, Wurz H, Hantke K, Rakin A, Yazdi AS, Matteoli G, Bohn E, Autenrieth IB, Karhausen J, Neumann D et al.: Hypoxia-independent activation of hif-1 by enterobacteriaceae and their siderophores. Gastroenterology 2008, 134:756-767.
58. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V, Johnson RS: Hif-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005, 115:1806-1815. (Pubitemid 40979719)
59. Schaible B, McClean S, Selfridge A, Broquet A, Asehnoune K, Taylor CT, Schaffer K: Hypoxia modulates infection of epithelial cells by Pseudomonas aeruginosa. PLoS ONE 2013, 8:e56491.
60. Okumura CY, Hollands A, Tran DN, Olson J, Dahesh S, von Kockritz-Blickwede M, Thienphrapa W, Corle C, Jeung SN, Kotsakis A, Shalwitz RA et al.: A new pharmacological agent (akb-4924) stabilizes hypoxia inducible factor-1 (hif-1) and increases skin innate defenses against bacterial infection. J Mol Med (Berl) 2012, 90:1079-1089.